Unraveling the complexity of Stenotrophomonas maltophilia – a comprehensive review of current knowledge

[1] Al-Anazi KA, Al-Jasser AM. Infections caused by Stenotrophomonas maltophilia in recipients of hematopoietic stem cell transplantation. Front. Oncol. 2014;4:232. Al-AnaziKA Al-JasserAM Infections caused by Stenotrophomonas maltophilia in recipients of hematopoietic stem cell transplantation Front. Oncol. 2014 4232 Search in Google Scholar

[2] McCutcheon JG, Dennis JJ. The potential of phage therapy against the emerging opportunistic pathogen Stenotrophomonas maltophilia. Viruses. 2021;13(6):1057. McCutcheonJG DennisJJ The potential of phage therapy against the emerging opportunistic pathogen Stenotrophomonas maltophilia Viruses. 2021 13 61057 Search in Google Scholar

[3] Kullar R, Wenzler E, Alexander J, Goldstein EJC. Overcoming Stenotrophomonas maltophilia resistance for a more rational therapeutic approach. Open Forum Infect Dis. 2022;9(5):ofac095. KullarR WenzlerE AlexanderJ GoldsteinEJC Overcoming Stenotrophomonas maltophilia resistance for a more rational therapeutic approach Open Forum Infect Dis. 2022 9 5 ofac095 Search in Google Scholar

[4] Adegoke AA, Stenström TA, Okoh AI. Stenotrophomonas maltophilia as an emerging ubiquitous pathogen: looking beyond contemporary antibiotic therapy. Front Microbiol. 2017;8:2276 AdegokeAA StenströmTA OkohAI Stenotrophomonas maltophilia as an emerging ubiquitous pathogen: looking beyond contemporary antibiotic therapy Front Microbiol. 2017 82276 Search in Google Scholar

[5] Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012;25(1):2–41 BrookeJS Stenotrophomonas maltophilia: an emerging global opportunistic pathogen Clin Microbiol Rev. 2012 25 1241 Search in Google Scholar

[6] Brooke JS. Advances in the microbiology of Stenotrophomonas maltophilia. Clin Microbiol Rev. 2021;34(3):e0003019 BrookeJS Advances in the microbiology of Stenotrophomonas maltophilia Clin Microbiol Rev. 2021 34 3 e0003019 Search in Google Scholar

[7] Yinsai O, Deeudom M, Duangsonk K. Genotypic diversity, antibiotic resistance, and virulence phenotypes of Stenotrophomonas maltophilia clinical isolates from a Thai university hospital setting. Antibiotics (Basel). 2023;12(2):410. YinsaiO DeeudomM DuangsonkK Genotypic diversity, antibiotic resistance, and virulence phenotypes of Stenotrophomonas maltophilia clinical isolates from a Thai university hospital setting Antibiotics (Basel). 2023 12 2410 Search in Google Scholar

[8] Elhalag KM, Emara HM, Messiha NAS, Elhadad SA, Abdallah SA. The relation of different crop roots exudates to the survival and suppressive effect of Stenotrophomonas maltophilia (PD4560), biocontrol agent of bacterial wilt of potato. J Phytopathol. 2015;163:829–840. ElhalagKM EmaraHM MessihaNAS ElhadadSA AbdallahSA The relation of different crop roots exudates to the survival and suppressive effect of Stenotrophomonas maltophilia (PD4560), biocontrol agent of bacterial wilt of potato J Phytopathol. 2015 163 829 840 Search in Google Scholar

[9] Lira F, Hernández A, Belda E, Sánchez MB, Moya A, Silva FJ, Martínez JL. Whole-genome sequence of Stenotrophomonas maltophilia D457, a clinical isolate and a model strain. J Bacteriol. 2012;194(13):3563–4 LiraF HernándezA BeldaE SánchezMB MoyaA SilvaFJ MartínezJL Whole-genome sequence of Stenotrophomonas maltophilia D457, a clinical isolate and a model strain J Bacteriol. 2012 194 1335634 Search in Google Scholar

[10] Bodilis J, Youenou B, Briolay J, Brothier E, Favre-Bonté S, Nazaret S. Draft genome sequences of Stenotrophomonas maltophilia strains Sm32COP, Sm41DVV, Sm46PAILV, SmF3, SmF22, SmSOFb1, and SmCVFa1, isolated from different manures in France. Genome Announc. 2016;4(4):e00841–16. BodilisJ YouenouB BriolayJ BrothierE Favre-BontéS NazaretS Draft genome sequences of Stenotrophomonas maltophilia strains Sm32COP, Sm41DVV, Sm46PAILV, SmF3, SmF22, SmSOFb1, and SmCVFa1, isolated from different manures in France Genome Announc. 2016 4 4 e00841 16 Search in Google Scholar

[11] Crossman LC, Gould VC, Dow JM, Vernikos GS, Okazaki A, Sebaihia M, Saunders D, Arrowsmith C, Carver T, Peters N. et. al. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 2008;9(4):R74. CrossmanLC GouldVC DowJM VernikosGS OkazakiA SebaihiaM SaundersD ArrowsmithC CarverT PetersN The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants Genome Biol. 2008 9 4 R74 Search in Google Scholar

[12] Patil PP, Midha S, Kumar S, Patil PB. Genome sequence of type strains of genus Stenotrophomonas. Front Microbiol. 2016;7:309 PatilPP MidhaS KumarS PatilPB Genome sequence of type strains of genus Stenotrophomonas Front Microbiol. 2016 7309 Search in Google Scholar

[13] Crisan CV, Duncan RP, Van Tyne D, Goldberg JB. Complete genome sequence of Stenotrophomonas maltophilia complex strain STEN00241. Microbiol Resour Announc. 2024;13(2):e0105323. CrisanCV DuncanRP Van TyneD GoldbergJB Complete genome sequence of Stenotrophomonas maltophilia complex strain STEN00241 Microbiol Resour Announc. 2024 13 2 e0105323 Search in Google Scholar

[14] Jefferson B, Yao G, Clark J, Le T, Gonzalez C, Liu M, Burrowes B. Complete genome sequence of Stenotrophomonas maltophilia siphophage salva. Microbiol Resour Announc. 2021;10(10):e00083–21 JeffersonB YaoG ClarkJ LeT GonzalezC LiuM BurrowesB Complete genome sequence of Stenotrophomonas maltophilia siphophage salva Microbiol Resour Announc. 2021 10 10 e00083 21 Search in Google Scholar

[15] Vicary A, Newkirk H, Moreland R, Gonzalez CF, Liu M, Ramsey J, Leavitt J. Complete genome sequence of Stenotrophomonas maltophilia myophage moby. Microbiol Resour Announc. 2020;9(1):e01422–19. VicaryA NewkirkH MorelandR GonzalezCF LiuM RamseyJ LeavittJ Complete genome sequence of Stenotrophomonas maltophilia myophage moby Microbiol Resour Announc. 2020 9 1 e01422 19 Search in Google Scholar

[16] Zhang M, Li L, Pan H, Zhou T. The complete genome sequence of a bile-isolated Stenotrophomonas maltophilia ZT1. Gut Pathog. 2021;13(1):64. ZhangM LiL PanH ZhouT The complete genome sequence of a bile-isolated Stenotrophomonas maltophilia ZT1 Gut Pathog. 2021 13 1 64 Search in Google Scholar

[17] Mercier-Darty M, Royer G, Lamy B, Charron C, Lemenand O, Gomart C, Fourreau F, Madec JY, Jumas-Bilak E, Decousser JW. Comparative whole-genome phylogeny of animal, environmental, and human strains confirms the genogroup organization and diversity of the Stenotrophomonas maltophilia complex. Appl Environ Microbiol. 2020;86(10):e02919–19. Mercier-DartyM RoyerG LamyB CharronC LemenandO GomartC FourreauF MadecJY Jumas-BilakE DecousserJW Comparative whole-genome phylogeny of animal, environmental, and human strains confirms the genogroup organization and diversity of the Stenotrophomonas maltophilia complex Appl Environ Microbiol. 2020 86 10 e02919 19 Search in Google Scholar

[18] Isom CM, Fort B, Anderson GG. Evaluating metabolic pathways and Biofilm formation in Stenotrophomonas maltophilia. J Bacteriol. 2022;204(1):e0039821. IsomCM FortB AndersonGG Evaluating metabolic pathways and Biofilm formation in Stenotrophomonas maltophilia J Bacteriol. 2022 204 1 e0039821 Search in Google Scholar

[19] Nangia Y, Wangoo N, Goyal N, Shekhawat G, Raman Suri C. A novel bacterial isolate Stenotrophomonas maltophilia as living factory for synthesis of gold nanoparticles. Microb Cell Fact. 2009;8:39. NangiaY WangooN GoyalN ShekhawatG Raman SuriC A novel bacterial isolate Stenotrophomonas maltophilia as living factory for synthesis of gold nanoparticles Microb Cell Fact. 2009 839 Search in Google Scholar

[20] Molloy K, Smith SG, Cagney G, Dillon ET, Greene CM, McElvaney NG. Characterisation of the major extracellular proteases of Stenotrophomonas maltophilia and their effects on pulmonary antiproteases. Pathogens. 2019;8(3):92. MolloyK SmithSG CagneyG DillonET GreeneCM McElvaneyNG Characterisation of the major extracellular proteases of Stenotrophomonas maltophilia and their effects on pulmonary antiproteases Pathogens. 2019 8 3 92 Search in Google Scholar

[21] Bhaumik R, Aungkur NZ, Anderson GG. A guide to Stenotrophomonas maltophilia virulence capabilities, as we currently understand them. Front Cell Infect Microbiol. 2024;11(13):1322853. BhaumikR AungkurNZ AndersonGG A guide to Stenotrophomonas maltophilia virulence capabilities, as we currently understand them Front Cell Infect Microbiol. 2024 11 13 1322853 Search in Google Scholar

[22] Alonso A, Sanchez P, Martínez JL. Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic and heavy metal resistance. Antimicrob Agents Chemother. 2000;44(7):1778–82. AlonsoA SanchezP MartínezJL Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic and heavy metal resistance Antimicrob Agents Chemother. 2000 44 7 1778 82 Search in Google Scholar

[23] Pruvost C, May L, Davous N, Petit A. pyodermite plantaire due à Stenotrophomonas maltophilia [Plantar pyoderma due to Stenotrophomonas maltophilia]. Ann Dermatol Venereol. 2002;129(6–7):886–7. PruvostC MayL DavousN PetitA pyodermite plantaire due à Stenotrophomonas maltophilia [Plantar pyoderma due to Stenotrophomonas maltophilia] Ann Dermatol Venereol. 2002 129 6–7 886 7 Search in Google Scholar

[24] Thomas R, Hamat RA, Neela V. Extracellular enzyme profiling of Stenotrophomonas maltophilia clinical isolates. Virulence. 2014;5(2):326–30. ThomasR HamatRA NeelaV Extracellular enzyme profiling of Stenotrophomonas maltophilia clinical isolates Virulence. 2014 5 2 326 30 Search in Google Scholar

[25] Wang M, Yin S, Qin Q, Peng Y, Hu Z, Zhu X, Liu L, Li X. Stenotrophomonasmaltophilia inhibits host cellular immunity by activating PD-1/PDL1 signaling pathway to induce T-cell exhaustion. Mol Immunol. 2021;130:37–48. WangM YinS QinQ PengY HuZ ZhuX LiuL LiX Stenotrophomonasmaltophilia inhibits host cellular immunity by activating PD-1/PDL1 signaling pathway to induce T-cell exhaustion Mol Immunol. 2021 130 37 48 Search in Google Scholar

[26] Sameni F, Hajikhani B, Hashemi A, Owlia P, Niakan M, Dadashi M. The relationship between the biofilm genes and antibiotic resistance in Stenotrophomonas maltophilia. Int J Microbiol. 2023;2023:8873948. SameniF HajikhaniB HashemiA OwliaP NiakanM DadashiM The relationship between the biofilm genes and antibiotic resistance in Stenotrophomonas maltophilia Int J Microbiol. 2023 20238873948 Search in Google Scholar

[27] DuMont AL, Cianciotto NP. Stenotrophomonas maltophilia serine protease StmPr1 induces matrilysis, anoikis, and protease-activated receptor 2 activation in human lung epithelial cells. Infect Immun. 2017;85(12):e00544–17. DuMontAL CianciottoNP Stenotrophomonas maltophilia serine protease StmPr1 induces matrilysis, anoikis, and protease-activated receptor 2 activation in human lung epithelial cells Infect Immun. 2017 85 12 e00544 17 Search in Google Scholar

[28] McKay GA, Woods DE, MacDonald KL, Poole K. Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance. Infection Immun. 2003;71:3068–3075. McKayGA WoodsDE MacDonaldKL PooleK Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance Infection Immun. 2003 71 3068 3075 Search in Google Scholar

[29] Alcaraz E, García C, Friedman L, de Rossi B P. The rpf/DSF signalling system of Stenotrophomonas maltophilia positively regulates biofilm formation, production of virulence-associated factors and β-lactamase induction. FEMS Microbiol Lett. 2019;366(6):fnz069. AlcarazE GarcíaC FriedmanL de RossiB P The rpf/DSF signalling system of Stenotrophomonas maltophilia positively regulates biofilm formation, production of virulence-associated factors and β-lactamase induction FEMS Microbiol Lett. 2019 366 6 fnz069 Search in Google Scholar

[30] Zhou YJ, Li G, Wang J, Liu M, Wang Z, Song Y, Zhang X, Wang X. PDL1: expression regulation. Blood Sci. 2023;5(2):77–91. ZhouYJ LiG WangJ LiuM WangZ SongY ZhangX WangX PDL1: expression regulation Blood Sci. 2023 5 2 77 91 Search in Google Scholar

[31] Wang L, Zhou W, Cao Y, Yang C, Liu H, Chen T, Chen L. Characteristics of Stenotrophomonas maltophilia infection in children in Sichuan, China, from 2010 to 2017. Medicine (Baltimore). 2020;99(8):e19250. WangL ZhouW CaoY YangC LiuH ChenT ChenL Characteristics of Stenotrophomonas maltophilia infection in children in Sichuan, China, from 2010 to 2017 Medicine (Baltimore). 2020 99 8 e19250 Search in Google Scholar

[32] Singhal L, Kaur P, Gautam V. Stenotrophomonas maltophilia: from trivial to grievous. Indian J Med Microbiol. 2017;35(4):469–479. SinghalL KaurP GautamV Stenotrophomonas maltophilia: from trivial to grievous Indian J Med Microbiol. 2017 35 4 469 479 Search in Google Scholar

[33] Said MS, Tirthani E, Lesho E. Stenotrophomonas maltophilia [Internet]. Treasure Island, FL: StatPearls Publishing; 2023. SaidMS TirthaniE LeshoE Stenotrophomonas maltophilia [Internet] Treasure Island, FL StatPearls Publishing 2023 Search in Google Scholar

[34] Looney WJ, Narita M, Mühlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis. 2009;9(5):312–23. LooneyWJ NaritaM MühlemannK Stenotrophomonas maltophilia: an emerging opportunist human pathogen Lancet Infect Dis. 2009 9 5 312 23 Search in Google Scholar

[35] Huang C, Kuo S, Lin L. Hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in patients with hematologic malignancies-a systematic review and meta-analysis. Medicina (Kaunas). 2024;60(1):162. HuangC KuoS LinL Hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in patients with hematologic malignancies-a systematic review and meta-analysis Medicina (Kaunas). 2024 60 1 162 Search in Google Scholar

[36] Goncalves-Vidigal P, Grosse-Onnebrink J, Mellies U, Buer J, Rath PM, Steinmann J. Stenotrophomonas maltophilia in cystic fibrosis: improved detection by the use of selective agar and evaluation of antimicrobial resistance. J Cyst Fibros. 2011;10(6):422–7. Goncalves-VidigalP Grosse-OnnebrinkJ MelliesU BuerJ RathPM SteinmannJ Stenotrophomonas maltophilia in cystic fibrosis: improved detection by the use of selective agar and evaluation of antimicrobial resistance J Cyst Fibros. 2011 10 6 422 7 Search in Google Scholar

[37] Insuwanno W, Kiratisin P, Jitmuang A. Stenotrophomonas maltophilia infections: clinical characteristics and factors associated with mortality of hospitalized patients. Infect Drug Resist. 2020;13:1559–1566. InsuwannoW KiratisinP JitmuangA Stenotrophomonas maltophilia infections: clinical characteristics and factors associated with mortality of hospitalized patients Infect Drug Resist. 2020 13 1559 1566 Search in Google Scholar

[38] Belzer A, Weiss E, Etaee F, Bunick CG, Damsky W, Nelson CA. Stenotrophomonas maltophilia, a pathogen of increasing relevance to dermatologists: A case report and review of the literature. Antibiotics (Basel). 2022;11(10):1398. BelzerA WeissE EtaeeF BunickCG DamskyW NelsonCA Stenotrophomonas maltophilia, a pathogen of increasing relevance to dermatologists: A case report and review of the literature Antibiotics (Basel). 2022 11 10 1398 Search in Google Scholar

[39] Chang YT, Lin CY, Chen YH, Hsueh PR. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol. 2015;6:893. ChangYT LinCY ChenYH HsuehPR Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options Front Microbiol. 2015 6893 Search in Google Scholar

[40] Adegoke AA, Stenström TA, Okoh AI. Stenotrophomonas maltophilia as an emerging ubiquitous pathogen: looking beyond contemporary antibiotic therapy. Front Microbiol. 2017;8:2276. AdegokeAA StenströmTA OkohAI Stenotrophomonas maltophilia as an emerging ubiquitous pathogen: looking beyond contemporary antibiotic therapy Front Microbiol. 2017 82276 Search in Google Scholar

[41] Alsuhaibani M, Aljarbou A, Althawadi S, Alsweed A, Al-Hajjar S. Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate. Antimicrob Resist Infect Control. 2021;10(1):19. AlsuhaibaniM AljarbouA AlthawadiS AlsweedA Al-HajjarS Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate Antimicrob Resist Infect Control. 2021 10 1 19 Search in Google Scholar

[42] Büyükcam A, Bıçakcıgil A, Cengiz AB, Sancak B, Ceyhan M, Kara A. Stenotrophomonas maltophilia bacteremia in children - A 10-year analysis. Arch Argent Pediatr. 2020;118(3):e317–e323. BüyükcamA BıçakcıgilA CengizAB SancakB CeyhanM KaraA Stenotrophomonas maltophilia bacteremia in children - A 10-year analysis Arch Argent Pediatr. 2020 118 3 e317 e323 Search in Google Scholar

[43] Neela V, Thomas R, Rankouhi SZR, Karunanidhi A, Shueh CS, Hamat RA, van Belkum A. modified DNase tube test to detect DNase activity in Stenotrophomonas maltophilia. 2012;61(Pt 12):1792–1794. NeelaV ThomasR RankouhiSZR KarunanidhiA ShuehCS HamatRA van BelkumA modified DNase tube test to detect DNase activity in Stenotrophomonas maltophilia 2012 61 Pt 12 1792 1794 Search in Google Scholar

[44] Gerceker D, Karasartova D, Elyürek E, Barkar S, Kiyan M, Ozsan TM, Calgin MK, Sahin F. A new, simple, rapid test for detection of DNase activity of microorganisms: DNase Tube test. J Gen Appl Microbiol. 2009;55(4):291–4. GercekerD KarasartovaD ElyürekE BarkarS KiyanM OzsanTM CalginMK SahinF A new, simple, rapid test for detection of DNase activity of microorganisms: DNase Tube test J Gen Appl Microbiol. 2009 55 4 291 4 Search in Google Scholar

[45] Okuno NT, Freire IR, Segundo RTRS, Silva CR, Marin VA. Polymerase chain reaction assay for detection of Stenotrophomonas maltophilia in cheese samples based on the smeT gene. 2018;75(12):1555–1559. OkunoNT FreireIR SegundoRTRS SilvaCR MarinVA Polymerase chain reaction assay for detection of Stenotrophomonas maltophilia in cheese samples based on the smeT gene 2018 75 12 1555 1559 Search in Google Scholar

[46] Hansen N, Rasmussen AK, Fiandaca MJ, Kragh KN, Bjarnsholt T, Høiby N, Stender H, Guardabassi L. Rapid identification of Stenotrophomonas maltophilia by peptide nucleic acid fluorescence in situ hybridization. New Microbes New Infect. 2014; 2(3):79–81. HansenN RasmussenAK FiandacaMJ KraghKN BjarnsholtT HøibyN StenderH GuardabassiL Rapid identification of Stenotrophomonas maltophilia by peptide nucleic acid fluorescence in situ hybridization New Microbes New Infect. 2014 2 3 79 81 Search in Google Scholar

[47] Fraser TA, Bell MG, Harris PNA, Bell SC, Bergh H, Nguyen TK, Kidd TJ, Nimmo GR, Sarovich DS, Price EP. Quantitative real-time PCR assay for the rapid identification of the intrinsically multidrug-resistant bacterial pathogen Stenotrophomonas maltophilia. Microb Genom. 2019;(10):e000307. FraserTA BellMG HarrisPNA BellSC BerghH NguyenTK KiddTJ NimmoGR SarovichDS PriceEP Quantitative real-time PCR assay for the rapid identification of the intrinsically multidrug-resistant bacterial pathogen Stenotrophomonas maltophilia Microb Genom. 2019 10 e000307 Search in Google Scholar

[48] Sánchez MB, Martínez JL. Overexpression of the Efflux Pumps SmeVWX and SmeDEF Is a major cause of resistance to Cotrimoxazole in Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 2018; 62(6):e00301–18. SánchezMB MartínezJL Overexpression of the Efflux Pumps SmeVWX and SmeDEF Is a major cause of resistance to Cotrimoxazole in Stenotrophomonas maltophilia Antimicrob Agents Chemother. 2018 62 6 e00301 18 Search in Google Scholar

[49] Zając OM, Tyski S, Laudy AE. The contribution of efflux systems to levofloxacin resistance in Stenotrophomonas maltophilia clinical strains isolated in Warsaw, Poland. Biology (Basel). 2022;11(7):1044. ZającOM TyskiS LaudyAE The contribution of efflux systems to levofloxacin resistance in Stenotrophomonas maltophilia clinical strains isolated in Warsaw, Poland Biology (Basel). 2022 11 7 1044 Search in Google Scholar

[50] Zhao J, Xing Y, Liu W, Ni W, Wei C, Wang R, Liu Y, Liu Y. Surveillance of dihydropteroate synthase genes in Stenotrophomonas maltophilia by LAMP: Implications for infection control and initial therapy. Front Microbiol. 2016;7:1723. ZhaoJ XingY LiuW NiW WeiC WangR LiuY LiuY Surveillance of dihydropteroate synthase genes in Stenotrophomonas maltophilia by LAMP: Implications for infection control and initial therapy Front Microbiol. 2016 71723 Search in Google Scholar

[51] Yang Z, Liu W, Cui Q, Niu W, Li H, Zhao X, Wei X, Wang X, Huang S, Dong D. et al. Prevalence and detection of Stenotrophomonas maltophilia carrying metallo-β-lactamase blaL1 in Beijing, China. Front Microbiol. 2014;5:692. YangZ LiuW CuiQ NiuW LiH ZhaoX WeiX WangX HuangS DongD Prevalence and detection of Stenotrophomonas maltophilia carrying metallo-β-lactamase blaL1 in Beijing, China Front Microbiol. 2014 5692 Search in Google Scholar

[52] Montoya-Hinojosa E, Bocanegra-Ibarias P, Garza-González E, Alonso-Ambriz ÓM, Salazar-Mata GA, Villarreal-Treviño L, Pérez-Alba E, Camacho-Ortiz A, Morfín-Otero R, Rodríguez-Noriega E. et al. Discrimination of biofilm-producing Stenotrophomonas maltophilia clinical strains by matrix-assisted laser desorption ionization-time of flight. PLoS One. 2020;15(12):e0244751. Montoya-HinojosaE Bocanegra-IbariasP Garza-GonzálezE Alonso-AmbrizÓM Salazar-MataGA Villarreal-TreviñoL Pérez-AlbaE Camacho-OrtizA Morfín-OteroR Rodríguez-NoriegaE Discrimination of biofilm-producing Stenotrophomonas maltophilia clinical strains by matrix-assisted laser desorption ionization-time of flight PLoS One. 2020 15 12 e0244751 Search in Google Scholar

[53] Gaudreau AM, Labrie J, Goetz C, Dufour S, Jacques M. Evaluation of MALDI-TOF mass spectrometry for the identification of bacteria growing as biofilms. J Microbiol Methods. 2018;145:79–81. GaudreauAM LabrieJ GoetzC DufourS JacquesM Evaluation of MALDI-TOF mass spectrometry for the identification of bacteria growing as biofilms J Microbiol Methods. 2018 145 79 81 Search in Google Scholar

[54] Lin Y, Wang BX, Zhang NN, Zhang L, Gao ZB, Tian J, Jiang X. analysis identified Stenotrophomonas maltophilia pneumonia in an infant suffering from unexplained very severe pneumonia. Front Pediatr. 2019;7:380. LinY WangBX ZhangNN ZhangL GaoZB TianJ JiangX analysis identified Stenotrophomonas maltophilia pneumonia in an infant suffering from unexplained very severe pneumonia Front Pediatr. 2019 7380 Search in Google Scholar

[55] Camargo JF, Ahmed AA, Lindner MS, Morris MI, Anjan S, Anderson AD, Prado CE, Dalai SC, Martinez OV, Komanduri KV. Next-generation sequencing of microbial cell-free DNA for rapid noninvasive diagnosis of infectious diseases in immunocompromised hosts. F1000Res. 2019;8:1194. CamargoJF AhmedAA LindnerMS MorrisMI AnjanS AndersonAD PradoCE DalaiSC MartinezOV KomanduriKV Next-generation sequencing of microbial cell-free DNA for rapid noninvasive diagnosis of infectious diseases in immunocompromised hosts F1000Res. 2019 81194 Search in Google Scholar

[56] Chang LL, Chen HF, Chang CY, Lee TM, Wu WJ. Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother. 2004;53(3):518–21. ChangLL ChenHF ChangCY LeeTM WuWJ Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia J Antimicrob Chemother. 2004 53 3 518 21 Search in Google Scholar

[57] Li XZ, Zhang L, Poole K. SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 2002;46(2):333–43. LiXZ ZhangL PooleK SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 2002 46 2 333 43 Search in Google Scholar

[58] Gould VC, Okazaki A, Howe RA, Avison MB. Analysis of sequence variation among smeDEF multi drug efflux pump genes and flanking DNA from defined 16S rRNA subgroups of clinical Stenotrophomonas maltophilia isolates. J Antimicrob Chemother. 2004;54(2):348–53. GouldVC OkazakiA HoweRA AvisonMB Analysis of sequence variation among smeDEF multi drug efflux pump genes and flanking DNA from defined 16S rRNA subgroups of clinical Stenotrophomonas maltophilia isolates J Antimicrob Chemother. 2004 54 2 348 53 Search in Google Scholar

[59] McDaniel MS, Schoeb T, Swords WE. Cooperativity between Stenotrophomonas maltophilia and pseudomonas aeruginosa during polymicrobial airway infections. Infect Immun. 2020;88(4):e00855–19. McDanielMS SchoebT SwordsWE Cooperativity between Stenotrophomonas maltophilia and pseudomonas aeruginosa during polymicrobial airway infections Infect Immun. 2020 88 4 e00855 19 Search in Google Scholar

[60] Barbolla R, Catalano M, Orman BE, Famiglietti A, Vay C, Smayevsky J, Centrón D, Piñeiro SA. Class 1 integrons increase trimethoprimsulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates. Antimicrob Agents Chemother. 2004;48(2):666–9. BarbollaR CatalanoM OrmanBE FamigliettiA VayC SmayevskyJ CentrónD PiñeiroSA Class 1 integrons increase trimethoprimsulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates Antimicrob Agents Chemother. 2004 48 2 666 9 Search in Google Scholar

[61] Kataoka D, Tanaka Y. The combination of aztreonam and cefozopran against Stenotrophomonas maltophilia. J Infect Chemother. 2004;10:62–64. KataokaD TanakaY The combination of aztreonam and cefozopran against Stenotrophomonas maltophilia J Infect Chemother. 2004 10 62 64 Search in Google Scholar

[62] Behera B. Letter in response to first case of persistent Stenotrophomonas maltophilia bacteraemia due to septic thrombosis successfully treated with a Cefiderocol-containing regimen. J Glob Antimicrob Resist. 2024;S2213–7165(24)00013–4. BeheraB Letter in response to first case of persistent Stenotrophomonas maltophilia bacteraemia due to septic thrombosis successfully treated with a Cefiderocol-containing regimen J Glob Antimicrob Resist. 2024 S2213–7165(24)00013–4 Search in Google Scholar

[63] Petraitis V, Petraitiene R, Kavaliauskas P, Naing E, Garcia A, Georgiades BN, Echols R, Bonomo RA, Yamano Y, Satlin MJ. et al. Effcacy of cefiderocol in experimental Stenotrophomonas maltophilia pneumonia in persistently neutropenic rabbits. Antimicrob Agents Chemother. 2022;66(10):e0061822. PetraitisV PetraitieneR KavaliauskasP NaingE GarciaA GeorgiadesBN EcholsR BonomoRA YamanoY SatlinMJ Effcacy of cefiderocol in experimental Stenotrophomonas maltophilia pneumonia in persistently neutropenic rabbits Antimicrob Agents Chemother. 2022 66 10 e0061822 Search in Google Scholar

[64] Werth BJ, Ashford NK, Penewit K, Waalkes A, Holmes EA, Bryan A, Salipante SJ. Evolution of cefiderocol resistance in Stenotrophomonas maltophilia using in vitro serial passage techniques. JAC Antimicrob Resist. 2022;4(1):dlac011. WerthBJ AshfordNK PenewitK WaalkesA HolmesEA BryanA SalipanteSJ Evolution of cefiderocol resistance in Stenotrophomonas maltophilia using in vitro serial passage techniques JAC Antimicrob Resist. 2022 4 1 dlac011 Search in Google Scholar

[65] Nakamura R, Oota M, Matsumoto S, Sato T, Yamano Y. In Vitro activity and In Vivo efficacy of Cefiderocol against Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 2021;65(4):e01436–20. NakamuraR OotaM MatsumotoS SatoT YamanoY In Vitro activity and In Vivo efficacy of Cefiderocol against Stenotrophomonas maltophilia Antimicrob Agents Chemother. 2021 65 4 e01436 20 Search in Google Scholar

[66] Rashid MH, Bukhari SNY, Mousa A, Aziz AA, Hakobyan K. Cefiderocol as a treatment option for Stenotrophomonas maltophilia causing hospital-acquired/ventilator-associated pneumonia. Cureus. 2023;15(5):e38613. RashidMH BukhariSNY MousaA AzizAA HakobyanK Cefiderocol as a treatment option for Stenotrophomonas maltophilia causing hospital-acquired/ventilator-associated pneumonia Cureus. 2023 15 5 e38613 Search in Google Scholar

[67] ClinicalTrials.gov [Internet]. Bethesda, (MD): National Library of Medicine (US); 2000. Identifier NCT05193058, description of lung transplant patients with microbiologically documented Stenotrophomonas Maltophilia pneumonia and impact of treatment on outcome (STENO_SOT); [updated 2022 Jan 14; cited 2024 Feb 20]; [about 4 screens]. Available from: http://clinicaltrials.gov/ct2/show/NCT05193058?cond=Stenotrophomonas+Maltophilia+Pneumonia&draw=2&rank=2 ClinicalTrials.gov [Internet] Bethesda, (MD) National Library of Medicine (US) 2000 Identifier NCT05193058, description of lung transplant patients with microbiologically documented Stenotrophomonas Maltophilia pneumonia and impact of treatment on outcome (STENO_SOT); [updated 2022 Jan 14; cited 2024 Feb 20]; [about 4 screens]. Available from: http://clinicaltrials.gov/ct2/show/NCT05193058?cond=Stenotrophomonas+Maltophilia+Pneumonia&draw=2&rank=2 Search in Google Scholar

[68] ClinicalTrials.gov [Internet]. Bethesda (MD): Methodist Dallas Medical Center (US); 2000. Identifier NCT06112938, alternative treatment strategies for Stenotrophomonas Maltophilia pneumonia; [updated 2023 Nov 2; cited 2024 Feb 20]; [about 3 screens]. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT06112938?cond=Stenotrophomonas+Maltophilia+Pneumonia&draw=2&rank=1 ClinicalTrials.gov [Internet] Bethesda (MD) Methodist Dallas Medical Center (US) 2000 Identifier NCT06112938, alternative treatment strategies for Stenotrophomonas Maltophilia pneumonia; [updated 2023 Nov 2; cited 2024 Feb 20]; [about 3 screens]. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT06112938?cond=Stenotrophomonas+Maltophilia+Pneumonia&draw=2&rank=1 Search in Google Scholar

[69] Al Johani SM, Akhter J, Balkhy H, El-Saed A, Younan M, Memish Z. Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia. Ann Saudi Med. 2010;30(5):364–9. Al JohaniSM AkhterJ BalkhyH El-SaedA YounanM MemishZ Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia Ann Saudi Med. 2010 30 5 364 9 Search in Google Scholar

[70] Avison MB, Higgins CS, von Heldreich CJ, Bennett PM, Walsh TR. Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 2001;45(2):413–9. AvisonMB HigginsCS von HeldreichCJ BennettPM WalshTR Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia Antimicrob Agents Chemother. 2001 45 2 413 9 Search in Google Scholar

[71] Gülmez D, Hasçelik G. Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital. Clin Microbiol Infect. 2005;11(11):880–6. GülmezD HasçelikG Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital Clin Microbiol Infect. 2005 11 11 880 6 Search in Google Scholar

[72] Liaw SJ, Lee YL, Hsueh PR. Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation. Int J Antimicrob Agents. 2010;35(2):126–30. LiawSJ LeeYL HsuehPR Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation Int J Antimicrob Agents. 2010 35 2 126 30 Search in Google Scholar

[73] Martínez JL. Antibiotics and antibiotic resistance genes in natural environments. Science. 2008;321(5887):365–7. MartínezJL Antibiotics and antibiotic resistance genes in natural environments Science. 2008 321 5887 365 7 Search in Google Scholar

[74] Poole K. Efflux-mediated multiresistance in gram-negative bacteria. Clin Microbiol Infect. 2004;10(1):12–26. PooleK Efflux-mediated multiresistance in gram-negative bacteria Clin Microbiol Infect. 2004 10 1 12 26 Search in Google Scholar

[75] Alonso A, Martínez JL. Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 2000; 44(11):3079–86 AlonsoA MartínezJL Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia Antimicrob Agents Chemother. 2000 44 11 3079 86 Search in Google Scholar

[76] Avison MB, von Heldreich CJ, Higgins CS, Bennett PM, Walsh TR. A TEM-2beta-lactamase encoded on an active Tn1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia. J Antimicrob Chemother. 2000;46(6):879–84. AvisonMB von HeldreichCJ HigginsCS BennettPM WalshTR A TEM-2beta-lactamase encoded on an active Tn1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia J Antimicrob Chemother. 2000 46 6 879 84 Search in Google Scholar

[77] Barbier-Frebour N, Boutiba-Boubake I, Nouvello M, Lemelan J. Molecular investigation of Stenotrophomonas maltophilia isolates exhibiting rapid emergence of ticarcillin-clavulanate resistance. J Hosp Infect. 2000;45(1):35–41. Barbier-FrebourN Boutiba-BoubakeI NouvelloM LemelanJ Molecular investigation of Stenotrophomonas maltophilia isolates exhibiting rapid emergence of ticarcillin-clavulanate resistance J Hosp Infect. 2000 45 1 35 41 Search in Google Scholar

[78] Toleman MA, Bennett PM, Bennett DM, Jones RN, Walsh TR. Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg Infect Dis. 2007;13(4):559–65. TolemanMA BennettPM BennettDM JonesRN WalshTR Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes Emerg Infect Dis. 2007 13 4 559 65 Search in Google Scholar

[79] Zhang L, Li X Z, Poole K. Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Antimicrob Agents Chemother. 2000;44(2):287–93. ZhangL LiX Z PooleK Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system Antimicrob Agents Chemother. 2000 44 2 287 93 Search in Google Scholar

[80] Valenza G, Tappe D, Turnwald D, Frosch M, König C, Hebestreit H, Abele-Horn M. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J Cyst Fibros. 2008;7(2):123–7. ValenzaG TappeD TurnwaldD FroschM KönigC HebestreitH Abele-HornM Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis J Cyst Fibros. 2008 7 2 123 7 Search in Google Scholar

[81] Rahmati-Bahram A, Magee JT, Jackson SK. Temperature-dependent aminoglycoside resistance in Stenotrophomonas (Xanthomonas) maltophilia; alterations in protein and lipopolysaccharide with growth temperature. J Antimicrob Chemother. 1996;37(4):665–76. Rahmati-BahramA MageeJT JacksonSK Temperature-dependent aminoglycoside resistance in Stenotrophomonas (Xanthomonas) maltophilia; alterations in protein and lipopolysaccharide with growth temperature J Antimicrob Chemother. 1996 37 4 665 76 Search in Google Scholar

[82] Hu LF, Chang X, Ye Y, Wang ZX, Shao YB, Shi W, Li X, Li JB. Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron. Int J Antimicrob Agents. 2011;37(3):230–4. HuLF ChangX YeY WangZX ShaoYB ShiW LiX LiJB Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron Int J Antimicrob Agents. 2011 37 3 230 4 Search in Google Scholar